Brandi Kennedy
Family Medicine · Statesville, NCNPI 1194211714
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 66 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 13.1% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $484, more than ten times the $11 reported in 2019.
Across 66 payments — averaging $18.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mayne Pharma Commercial LLC$158
- AbbVie$133
- Biogen$126
- Shield Therapeutics Inc$125
- Organon$99
- Bayer$69
- plus $493 from 16 others
What the payments were for
- Food & beverage$1,202100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Mayne Pharma Commercial LLC | 8 | $158 |
| AbbVie | 7 | $133 |
| Biogen | 5 | $126 |
| Shield Therapeutics Inc | 8 | $125 |
| Organon | 7 | $99 |
| Bayer | 3 | $69 |
| Evofem Biosciences, Inc. | 4 | $67 |
| Pfizer | 3 | $50 |
| Lilly USA, LLC | 3 | $46 |
| Novo Nordisk | 2 | $39 |
| Astellas Pharma US Inc | 2 | $39 |
| Exeltis, USA Inc. | 2 | $34 |
| Davol Inc. | 1 | $32 |
| Merck | 2 | $28 |
| Coopersurgical, Inc. | 2 | $26 |
| Hologic Sales And Service, LLC | 1 | $24 |
| Sanofi Pasteur Inc. | 1 | $20 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $19 |
| LSI Solutions Inc | 1 | $19 |
| Boston Scientific | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
| Smith+Nephew | 1 | $16 |
How this compares
$1,202 in reported general payments places this provider in the 70th percentile of 3,444 family medicine providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Rosuvastatin Calcium | 12 | $99 |
| Lisinopril | 13 | $61 |
| Losartan Potassium | 12 | $47 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Statesville
- William CromwellRaleigh$879K
- Steve VacalisGastonia$693K
- David DundeeWinston Salem$633K
- Kevin SodenCharlotte$558K
- Brian ForrestApex$398K
- Joseph KonenCharlotte$322K
- Richard RachimaCharlotte$294K
- Dimitrios HondrosCharlotte$275K
- Domingo Rodriguez-CueGarner$253K
- Christopher ChaoCary$201K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.